AVROBIO INC's ticker is AVRO and the CUSIP is 05455M100. A total of 47 filers reported holding AVROBIO INC in Q4 2023. The put-call ratio across all filers is 0.01 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2024 | $1,137 | +10.2% | 888,167 | +17.0% | 0.00% | 0.0% |
Q4 2023 | $1,032 | +29.3% | 758,943 | +46.4% | 0.00% | +100.0% |
Q3 2023 | $798 | +49.4% | 518,467 | -7.8% | 0.00% | 0.0% |
Q2 2023 | $534 | -6.8% | 562,567 | -1.9% | 0.00% | 0.0% |
Q1 2023 | $573 | -6.8% | 573,367 | -33.5% | 0.00% | 0.0% |
Q4 2022 | $615 | -99.9% | 862,267 | -29.4% | 0.00% | 0.0% |
Q3 2022 | $785,000 | -45.1% | 1,222,141 | -21.4% | 0.00% | -50.0% |
Q2 2022 | $1,431,000 | +22.5% | 1,555,800 | +75.8% | 0.00% | +100.0% |
Q1 2022 | $1,168,000 | -5.5% | 885,100 | +175.7% | 0.00% | -50.0% |
Q4 2021 | $1,236,000 | -45.3% | 321,000 | -20.8% | 0.00% | -33.3% |
Q3 2021 | $2,260,000 | +185.7% | 405,100 | +355.2% | 0.00% | +200.0% |
Q2 2021 | $791,000 | +39.8% | 89,000 | +119.2% | 0.00% | 0.0% |
Q4 2020 | $566,000 | +184.4% | 40,600 | +165.4% | 0.00% | – |
Q3 2020 | $199,000 | -68.8% | 15,300 | -58.1% | 0.00% | -100.0% |
Q2 2020 | $637,000 | +145.9% | 36,530 | +129.7% | 0.00% | – |
Q2 2019 | $259,000 | – | 15,900 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SV Health Investors, LLC | 1,236,123 | $19,234,000 | 16.13% |
Aisling Capital Management LP | 1,009,779 | $15,712,000 | 6.84% |
Burrage Capital Management LLC | 225,900 | $3,273,000 | 3.22% |
TANG CAPITAL MANAGEMENT LLC | 1,000,000 | $15,560,000 | 2.18% |
Parkman Healthcare Partners LLC | 295,593 | $4,599,000 | 2.13% |
New Leaf Venture Partners, L.L.C. | 315,550 | $4,910,000 | 1.47% |
Asymmetry Capital Management, L.P. | 85,554 | $1,331,000 | 1.46% |
Camber Capital Management LP | 1,350,000 | $21,006,000 | 1.25% |
Pinz Capital Management, LP | 26,531 | $413,000 | 1.08% |
Vivo Capital, LLC | 717,753 | $11,168,000 | 1.01% |